Corvair Monza is an AI-enabled medical device from AliveCor, Inc., listed by FDA (510(k), K252589) with a decision date of 2026-01-09. Review panel: Cardiovascular.
| FDA submission number | K252589 |
|---|---|
| Pathway | 510(k) |
| Company | AliveCor, Inc. |
| Review panel (specialty) | Cardiovascular |
| FDA decision date | 2026-01-09 |
| Decision | Substantially Equivalent |
| Product code | MHX |
| Classification | Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) |
| Device class | 2 |
| Regulation number | 870.1025 |
| Review time (calendar days) | 147 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
More devices from AliveCor, Inc. · All Cardiovascular AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.